Author

S. J. Kaptein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

J. Neyts· 2 shared K. Dallmeier· 2 shared A. Bujko· 1 shared A. Goncalves· 1 shared A. Hoorens· 1 shared A. Remmerie· 1 shared A. Vanlander· 1 shared A. Willaert· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. Neyts

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial proteogenomics reveals distinct and evolutionarily-conserved hepatic macrophage niches

M. Guilliams, J. Bonnardel, B. Haest, B. Vanderborght, A. Bujko, L. Martens, T. Thone, R. Browaeys, F. F. De Ponti, A. Remmerie, C. Wagner, B. Vanneste, C. Zwicker, T. Vanhalewyn, A. Goncalves, , C. L. Scott

This study creates a spatial proteogenomic atlas of the liver across species, identifying conserved macrophage niches and their regulatory mechanisms.

bioRxiv · Oct 15, 2021Immunology

Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine

S. J. Kaptein, S. Jacobs, L. Langendries, L. Seldeslachts, S. ter Horst, L. Liesenborghs, B. Hens, V. Vergote, E. Heylen, E. Maas, C. De Keyzer, L. Bervoets, J. Rymenants, T. Van Buyten, H. J. Thibaut, , L. Delang

This study evaluates the antiviral effects of favipiravir and hydroxychloroquine in SARS-CoV-2-infected hamsters, finding limited efficacy for both drugs.

bioRxiv · Jun 19, 2020 · PreprintMicrobiology